DePuy Hip Recall & Tea Leaves

November 7, 2013 – When you follow large, complex class action or mass tort products liability litigation matters, as we have been doing for several years with the DePuy ASR artificial hip lawsuits, it’s hard to predict with any degree of accuracy when things are finally going to end.

But there are signs that things could be coming to a femoral head on this litigation in the not-too-distant future.

From the March, 2009 filing of the first products liability lawsuit against DePuy alleging its ASR artificial hips were defective;

Through the August, 2010 worldwide recall of the device by DePuy Orthopaedics;

Through the December, 2010 multidistrict litigation (MDL) consolidation of a number of cases in Northern Ohio;

Through the $8.35 million verdict in Los Angeles – Kransky v. DePuy Orthopaedics, Inc. – in March, 2013;

Through a couple of recent postponements of several bellwether cases scheduled to begin this year and ongoing rumblings that Johnson & Johnson, DePuy’s parent company, has been weighing a $3.0 billion offer to settle more than 11,000 of the pending lawsuits;

Our firm has been monitoring this matter with great personal and professional interest.

And while we’re not taking any wagers on the matter, our tea leaves are leading us to believe this matter could be on the cusp of resolving.

If and when any plaintiffs involved in the DePuy ASR hip litigation do find themselves anticipating any settlements, we hope they’ll let us talk to them about the benefits of structuring their settlement.

We understand. We listen. We care.

That’s why three years ago we created a special companion website

ASRHipSettlement.com